BiOasis Presents at BIO Investor Forum Oct 17th
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 08, 2018 05:40PM
|
Re: We got the late-breaker :)
|
1
|
Resverlogix Corp.
|
Feb 18, 2020 01:59PM
|
More BET Publications and New Indications
|
1
|
Zenith Epigenetics
|
Dec 28, 2018 05:14PM
|
Re: Bear- organoids ?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jan 29, 2018 11:00AM
|
Resverlogix on schedule to present at BIO CEO Tuesday 2/13
|
1
|
Resverlogix Corp.
|
Feb 06, 2018 04:58PM
|
BIO International 2018 Slide Deck
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 12, 2018 10:38AM
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2018 10:37PM
|
Bioasis Further Strengthens Scientific Advisory Board
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 12, 2018 10:42AM
|
Phase 1b/2 trial expected to initiate 1Q 2019
|
1
|
Zenith Epigenetics
|
Mar 06, 2019 10:45AM
|
Bioasis Corporate Presentation Slide Deck from March 2019
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 08, 2019 12:12PM
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 01:32PM
|
Quarterly filings 10/30/17
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 31, 2017 03:39PM
|
Re: ... this from our girl in IR...
|
1
|
Resverlogix Corp.
|
Jun 08, 2018 04:11PM
|
Re: An invitation to join the conversation here on Agoracom
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 21, 2018 04:23PM
|
Presentation is over
|
1
|
Resverlogix Corp.
|
Jun 09, 2020 06:48AM
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2018 11:00PM
|
Bioasis Announces Private Placement and Intention to Pursue NASDAQ Listing
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 14, 2018 10:23AM
|
Re: Bioasis- Agoracom
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 21, 2018 04:25PM
|
Re: Pointing in the right direction & bogus Lilly
|
1
|
Resverlogix Corp.
|
Dec 01, 2018 04:29PM
|
Sangamo In Vivo Gene Editing for Enzyme/Protein Replacement Therapy
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 17, 2017 10:42AM
|